GLOBUS MEDICAL INC
GMEDUS売上高
$2.9B
百万USD
営業利益
$480M
百万USD
純利益
$538M
百万USD
ROE
11.8%
最新FY
EPS
$3.92
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $227M | $45M | $0.44 |
| FY2021 | Q2 | $251M | $42M | $0.40 |
| FY2021 | Q3 | $230M | $47M | $0.45 |
| FY2021 | FY | $958M | $149M | $1.44 |
| FY2022 | Q1 | $231M | $38M | $0.37 |
| FY2022 | Q2 | $264M | $55M | $0.53 |
| FY2022 | Q3 | $254M | $47M | $0.47 |
| FY2022 | FY | $1.0B | $190M | $1.85 |
| FY2023 | Q1 | $277M | $49M | $0.48 |
| FY2023 | Q2 | $292M | $58M | $0.57 |
| FY2023 | Q3 | $384M | $1M | $0.01 |
| FY2023 | FY | $1.6B | $123M | $1.07 |
| FY2024 | Q1 | $607M | $-7M | $-0.05 |
| FY2024 | Q2 | $630M | $32M | $0.23 |
| FY2024 | Q3 | $626M | $52M | $0.38 |
| FY2024 | FY | $2.5B | $103M | $0.75 |
| FY2025 | Q1 | $598M | $75M | $0.54 |
| FY2025 | Q2 | $745M | $203M | $1.49 |
| FY2025 | Q3 | $769M | $119M | $0.88 |
| FY2025 | FY | $2.9B | $538M | $3.92 |
| FY2026 | Q1 | $760M | $124M | $0.90 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $713M | $785M | $789M | $958M | $1.0B | $1.6B | $2.5B | $2.9B |
| 営業利益 | $154M | $162M | $169M | $172M | $111M | $172M | $228M | $133M | $166M | $480M |
| 純利益 | $104M | $107M | $156M | $155M | $102M | $149M | $190M | $123M | $103M | $538M |
| 総資産 | $928M | $1.1B | $1.3B | $1.5B | $1.7B | $2.0B | $2.1B | $5.1B | $5.3B | $5.3B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $832M | $968M | $1.2B | $1.4B | $1.5B | $1.7B | $1.8B | $4.0B | $4.2B | $4.6B |
| 営業CF | $172M | $160M | $182M | $172M | $199M | $276M | $178M | $243M | $521M | $753M |
| EPS | $1.08 | $1.10 | $1.54 | $1.52 | $1.01 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 |
| BPS | $8.67 | $10.01 | $12.02 | $14.05 | $15.09 | $17.15 | $18.40 | $29.53 | $30.37 | $33.81 |
| ROE | 12.5% | 11.1% | 13.2% | 11.1% | 6.8% | 8.6% | 10.3% | 3.1% | 2.5% | 11.8% |